# Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease

> **NCT02533349** · PHASE3 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Laryngopharyngeal Reflux Disease

## Interventions

- **DRUG:** Motilitone
- **DRUG:** Pantoprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02533349
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02533349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02533349, "Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02533349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*